When we feed the body correctly, we can influence the same systems that drugs like Mounjaro target - helping regulate ...

As weight-loss injections like Mounjaro and Wegovy soar in popularity across the UK, jewellers say they’re seeing an unexpected side effect: wedding and engagement rings no longer fit, and in they are ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

FAT jabs are ruining dinner parties as guests on weight-loss drugs lose their appetites. A survey found one in three hosts ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

The 10-year plan for the health service says there is a need to expand access to weight-loss services and treatments and ...

NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.

A University of Dundee spin-out has formed a new company dedicated to developing new obesity therapies that avoid the muscle ...

Viking Therapeutics (VKTX 1.70%) is developing VK2735, a dual GLP-1/GIP receptor agonist for obesity treatment. The company ...

There are some potential downsides though, including misuse by those who do not need to lose weight, some gastric side-effects and in limited cases, potentially pancreatitis and gall bladder disorders ...

Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating ...

After losing 6st within a year of taking the weight-loss drug, one mother-of-three says she plans to stay on it for the rest of her life ...